Healthcare Services

Global Gastric Volvulus Treatment Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Gastric Volvulus Treatment Market At The End Of The 2026–2030 Forecast Period?

The gastric volvulus treatment market size has demonstrated significant expansion in recent years. It is anticipated to increase from $28.86 billion in 2025 to $30.8 billion in 2026, advancing at a compound annual growth rate (CAGR) of 6.7%. This growth witnessed during the historical period can be primarily ascribed to the availability of surgical treatment options, the expansion of hospital emergency care, more effective diagnosis through imaging tests, the evolution of gastropexy procedures, and the progression in surgical expertise.

The gastric volvulus treatment market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $39.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. Several factors are expected to drive this growth during the forecast period, including the rise in minimally invasive surgical procedures, enhancements in emergency response systems, the uptake of advanced imaging technologies, the proliferation of specialized surgical centers, and a heightened understanding among clinicians. Key trends anticipated during this period encompass a growing inclination towards surgical interventions, greater acceptance of minimally invasive techniques, better emergency diagnosis and patient management, the broadening of specialized surgical care, and an emphasis on swift treatment strategies to lower mortality rates.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

Which Market Drivers Are Supporting The Expansion Of The Gastric Volvulus Treatment Market?

The expansion of the gastric volvulus treatment market is projected to be driven by an increasing geriatric demographic in the future. Specifically, the term ‘geriatric population’ denotes individuals aged 65 years and older. This demographic typically experiences a range of health issues, often attributable to diminished immunity and the aging process. Gastric volvulus itself is observed in adults exceeding the age of 50. Consequently, the expanding number of elderly individuals is anticipated to boost the market’s trajectory. Illustratively, data from January 2024, released by the US-based nonprofit organization Population Reference Bureau (PRB), predicts a significant rise in the American population aged 65 and over, from 58 million in 2022 to 82 million by 2050, representing a 47% increase. This demographic’s share of the total population is also expected to grow from 17% to 23%. Thus, the growing geriatric populations are acting as a primary catalyst for the gastric volvulus treatment market.

What Segment Types Make Up The Gastric Volvulus Treatment Market?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques

What Trends Are Advancing Progress In The Gastric Volvulus Treatment Market?

Major companies within the gastric volvulus treatment market are channeling their efforts into developing innovative solutions, including next-generation oral immunomodulatory therapies, to address the growing demand for advanced treatment options that enhance long-term disease control and patient quality of life. These therapies, administered orally, target inflammatory and immune-driven mechanisms, offering a more convenient and precise alternative to traditional systemic treatments that might involve higher side-effect risks and necessitate more rigorous management. As an illustration, in October 2023, Pfizer Inc., a pharmaceutical company based in the US, announced that the U.S. Food and Drug Administration (FDA) had given its approval to VELSIPITY (etrasimod). VELSIPITY (etrasimod) is an oral sphingosine-1-phosphate (S1P) receptor activator taken once daily for individuals with moderate to severe active ulcerative colitis (UC). The official suggested dosage for VELSIPITY is 2 mg. ELSIPITY allows adults experiencing moderately to severely active UC to achieve steroid-free resolution using a once-daily oral pill that exhibits a positive benefit-risk profile. The FDA’s approval of VELSIPITY today represents a significant turning point for UC patients who require novel therapies for this chronic illness and are prepared to initiate advanced treatment.

Who Are The Key Players Driving Competition In The Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.

Read the full gastric volvulus treatment market report here:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

How Is The Gastric Volvulus Treatment Market Distributed Across Key Geographic Regions?

North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastric Volvulus Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2026, By The Business Research Company

Peptic Ulcer Global Market Report

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Pressure Ulcers Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report

Duodenal Ulcer Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795